The Israeli public health response to wild poliovirus importation

Ehud Kaliner; Eran Kopel; Emilia Anis; Ella Mendelson; Jacob Moran-Gilad; Lester M. Shulman; Shepherd R. Singer; Yossi Manor; Eli Somekh; Shmuel Rishpon; Alex Leventhal; Lisa Rubin; Diana Tasher; Mira Honovich; Larisa Moerman; Tamy Shohat; Ravit Bassal; Danit Sofer; Michael Gdalevich; Boaz Lev; Ronni Gamzu; Itamar Grotto

doi:10.1016/S1473-3099(15)00064-X

The Israeli public health response to wild poliovirus importation

Ehud Kaliner, Eran Kopel, Emilia Anis, Ella Mendelson, Jacob Moran-Gilad, Lester M. Shulman, Shepherd R. Singer, Yossi Manor, Eli Somekh, Shmuel Rishpon, Alex Leventhal, Lisa Rubin, Diana Tasher, Mira Honovich, Larisa Moerman, Tamy Shohat, Ravit Bassal, Danit Sofer, Michael Gdalevich, Boaz LevRonni Gamzu, Itamar Grotto

School of Public Health

Research output: Contribution to journal › Comment/Debate

Abstract

In 2013, a silent wild poliovirus type 1 importation and sustained transmission event occurred in southern Israel. With the aim of preventing clinical poliomyelitis and ensuring virus re-elimination, the public health response to the importation event included intensifi cation of clinical and environmental surveillance activities, enhancement of vaccine coverage, and supplemental immunisation with a bivalent oral polio vaccine against wild poliovirus types 1 and 3. A national campaign launched in August, 2013, resulted in vaccination of 943 587 children younger than 10 years (79% of the eligible target population). Expanded environmental surveillance (roughly 80% population coverage) documented a gradual disappearance of wild poliovirus type 1 in the country from September, 2013, to April, 2014. No paralytic poliomyelitis case was detected. A prompt extensive and coordinated national public health response, implemented on the basis of evidence-based decision making, successfully contained this serious importation and sustained transmission event of wild poliovirus to Israel. On April 28, 2015, WHO offi cially declared Israel as a polio-free country.

Original language	English
Article number	70
Pages (from-to)	1236-1242
Number of pages	7
Journal	The Lancet Infectious Diseases
Volume	15
Issue number	10
DOIs	https://doi.org/10.1016/S1473-3099(15)00064-X
State	Published - 1 Oct 2015

Bibliographical note

Funding Information:
LMS has received a WHO grant for environmental surveillance of poliovirus to his institution and support from WHO for travel to WHO meetings and from the US Food and Drug Administration for travel to a workshop at the US National Institutes of Health. All other authors declare no competing interests.

Publisher Copyright:
© 2013.

ASJC Scopus subject areas

Infectious Diseases

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S1473-3099(15)00064-X

Cite this

Kaliner, E., Kopel, E., Anis, E., Mendelson, E., Moran-Gilad, J., Shulman, L. M., Singer, S. R., Manor, Y., Somekh, E., Rishpon, S., Leventhal, A., Rubin, L., Tasher, D., Honovich, M., Moerman, L., Shohat, T., Bassal, R., Sofer, D., Gdalevich, M., ... Grotto, I. (2015). The Israeli public health response to wild poliovirus importation. The Lancet Infectious Diseases, 15(10), 1236-1242. Article 70. https://doi.org/10.1016/S1473-3099(15)00064-X

@article{af2a8988b2ac44fd9da0f38c2a9c9135,

title = "The Israeli public health response to wild poliovirus importation",

abstract = "In 2013, a silent wild poliovirus type 1 importation and sustained transmission event occurred in southern Israel. With the aim of preventing clinical poliomyelitis and ensuring virus re-elimination, the public health response to the importation event included intensifi cation of clinical and environmental surveillance activities, enhancement of vaccine coverage, and supplemental immunisation with a bivalent oral polio vaccine against wild poliovirus types 1 and 3. A national campaign launched in August, 2013, resulted in vaccination of 943 587 children younger than 10 years (79% of the eligible target population). Expanded environmental surveillance (roughly 80% population coverage) documented a gradual disappearance of wild poliovirus type 1 in the country from September, 2013, to April, 2014. No paralytic poliomyelitis case was detected. A prompt extensive and coordinated national public health response, implemented on the basis of evidence-based decision making, successfully contained this serious importation and sustained transmission event of wild poliovirus to Israel. On April 28, 2015, WHO offi cially declared Israel as a polio-free country.",

author = "Ehud Kaliner and Eran Kopel and Emilia Anis and Ella Mendelson and Jacob Moran-Gilad and Shulman, {Lester M.} and Singer, {Shepherd R.} and Yossi Manor and Eli Somekh and Shmuel Rishpon and Alex Leventhal and Lisa Rubin and Diana Tasher and Mira Honovich and Larisa Moerman and Tamy Shohat and Ravit Bassal and Danit Sofer and Michael Gdalevich and Boaz Lev and Ronni Gamzu and Itamar Grotto",

note = "Funding Information: LMS has received a WHO grant for environmental surveillance of poliovirus to his institution and support from WHO for travel to WHO meetings and from the US Food and Drug Administration for travel to a workshop at the US National Institutes of Health. All other authors declare no competing interests. Publisher Copyright: {\textcopyright} 2013.",

year = "2015",

month = oct,

day = "1",

doi = "10.1016/S1473-3099(15)00064-X",

language = "English",

volume = "15",

pages = "1236--1242",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Lancet Publishing Group",

number = "10",

}

Kaliner, E, Kopel, E, Anis, E, Mendelson, E, Moran-Gilad, J, Shulman, LM, Singer, SR, Manor, Y, Somekh, E, Rishpon, S, Leventhal, A, Rubin, L, Tasher, D, Honovich, M, Moerman, L, Shohat, T, Bassal, R, Sofer, D, Gdalevich, M, Lev, B, Gamzu, R & Grotto, I 2015, 'The Israeli public health response to wild poliovirus importation', The Lancet Infectious Diseases, vol. 15, no. 10, 70, pp. 1236-1242. https://doi.org/10.1016/S1473-3099(15)00064-X

TY - JOUR

T1 - The Israeli public health response to wild poliovirus importation

AU - Kaliner, Ehud

AU - Kopel, Eran

AU - Anis, Emilia

AU - Mendelson, Ella

AU - Moran-Gilad, Jacob

AU - Shulman, Lester M.

AU - Singer, Shepherd R.

AU - Manor, Yossi

AU - Somekh, Eli

AU - Rishpon, Shmuel

AU - Leventhal, Alex

AU - Rubin, Lisa

AU - Tasher, Diana

AU - Honovich, Mira

AU - Moerman, Larisa

AU - Shohat, Tamy

AU - Bassal, Ravit

AU - Sofer, Danit

AU - Gdalevich, Michael

AU - Lev, Boaz

AU - Gamzu, Ronni

AU - Grotto, Itamar

N1 - Funding Information: LMS has received a WHO grant for environmental surveillance of poliovirus to his institution and support from WHO for travel to WHO meetings and from the US Food and Drug Administration for travel to a workshop at the US National Institutes of Health. All other authors declare no competing interests. Publisher Copyright: © 2013.

PY - 2015/10/1

Y1 - 2015/10/1

N2 - In 2013, a silent wild poliovirus type 1 importation and sustained transmission event occurred in southern Israel. With the aim of preventing clinical poliomyelitis and ensuring virus re-elimination, the public health response to the importation event included intensifi cation of clinical and environmental surveillance activities, enhancement of vaccine coverage, and supplemental immunisation with a bivalent oral polio vaccine against wild poliovirus types 1 and 3. A national campaign launched in August, 2013, resulted in vaccination of 943 587 children younger than 10 years (79% of the eligible target population). Expanded environmental surveillance (roughly 80% population coverage) documented a gradual disappearance of wild poliovirus type 1 in the country from September, 2013, to April, 2014. No paralytic poliomyelitis case was detected. A prompt extensive and coordinated national public health response, implemented on the basis of evidence-based decision making, successfully contained this serious importation and sustained transmission event of wild poliovirus to Israel. On April 28, 2015, WHO offi cially declared Israel as a polio-free country.

AB - In 2013, a silent wild poliovirus type 1 importation and sustained transmission event occurred in southern Israel. With the aim of preventing clinical poliomyelitis and ensuring virus re-elimination, the public health response to the importation event included intensifi cation of clinical and environmental surveillance activities, enhancement of vaccine coverage, and supplemental immunisation with a bivalent oral polio vaccine against wild poliovirus types 1 and 3. A national campaign launched in August, 2013, resulted in vaccination of 943 587 children younger than 10 years (79% of the eligible target population). Expanded environmental surveillance (roughly 80% population coverage) documented a gradual disappearance of wild poliovirus type 1 in the country from September, 2013, to April, 2014. No paralytic poliomyelitis case was detected. A prompt extensive and coordinated national public health response, implemented on the basis of evidence-based decision making, successfully contained this serious importation and sustained transmission event of wild poliovirus to Israel. On April 28, 2015, WHO offi cially declared Israel as a polio-free country.

UR - http://www.scopus.com/inward/record.url?scp=84942196262&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(15)00064-X

DO - 10.1016/S1473-3099(15)00064-X

M3 - Comment/Debate

C2 - 26213249

AN - SCOPUS:84942196262

SN - 1473-3099

VL - 15

SP - 1236

EP - 1242

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 10

M1 - 70

ER -

The Israeli public health response to wild poliovirus importation

Abstract

Bibliographical note

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this